Defecetive Drugs: adrugrecall.com
NEWS
- Accutane
- Advair
- Avandia
- Bextra
- Botox
- Byetta®
- CellCept
- Chantix
- Cipro
- Crestor
- Digitek
- Duragesic Patch
- Fleet Phospho Soda
- Floxin
- Fluoroquinolone
- Fosamax
- Gardasil
- Heparin
- Hydroxycut
- Levaquin
- MRI Dye
- Neurontin
- Noroxin
- Nuvaring
- Ortho Evra
- Paxil
- Permax
- PTU
- Raptiva
- Reglan
- Risperdal
- Serevent
- Seroquel
- Trasylol
- Viagra
- Vioxx
- Yasmin
- Zelnorm
- Zicam
- Zyprexa
Contact Us Today
Use this form to request a free consultation with a qualified attorney near you.
Your privacy is important to us. Any information submitted to this form is guaranteed safe, secure, and private.
Pfizer continues to defends its controversial drug Celebrex
December 20, 2004
Despite the recent announcement that Celebrex has been linked to double the risk of heart attack and stroke, causing the National Cancer Institute to suspend a trial because of the dangerous effects, Pfizer Inc. is standing by its arthritis painkiller. According to Pfizer Inc. Chairman and Chief Executive Hank McKinnell, "For millions of patients, Celebrex is the best option, or in some cases, the last option to live a normal life with the pain and inflammation of arthritis."
McKinnell's comments came two days after the FDA issued a warning to doctors of the Celebrex heart attack and stroke risks, as well as urging doctors to consider prescribing alternative medications. The FDA says it is considering implementing more stringent warnings or banning Celebrex from the market.
FDA acting director of drug safety and recent whistleblower, Dr. David Graham, described the Celebrex side effects saying, "I would be very concerned." The Celebrex warning follows just 11 weeks after Merck & Co. announced it was withdrawing rival drug Vioxx from the market in the largest prescription drug recall in history. Vioxx was recalled after similar findings of heart attack and stroke risks were discovered in a study.
Problems with both Vioxx and Celebrex, part of the COX-2 inhibitor class of drugs, has raised questions about the entire class of painkillers. After the Vioxx recall, just two COX-2 drugs remained on the market- Pfizer's Celebrex and Bextra. The Public Citizen consumer advocacy group has been preparing a petition asking the FDA to immediately ban both Celebrex and Bextra from the market because of safety concerns.For more information on Celebrex warnings, please contact us to confer with a Celebrex Lawyer and learn your legal rights and options.
More Recent Defective Drug News
- Popular Drug Recalls: Avandia
- Yaz Birth Control
- NuvaRing
- Reglan
- Home
- Drug Index
- News Archive
- Resources